Biological Shipping Blog, Cold Chain Transport Blog

Are You Securing “Smooth” Compliant Movement of Your Biological Materials?

Wed, Sep 12, 2018

Moving time and temperature sensitive biological materials “smoothly” across the globe, from A to B, is and requires more than “just” acquiring compliant packaging material and booking a carrier… While this may seem logic, how are you ensuring visibility to the Chain of Custody, Chain of Condition and more importantly Chain of Compliance™ for your shipment?

Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, temperature controlled logistics, cryogenic shipping, cold chain shipping, biologics, transportation

Compliance Considerations Driving Temperature-Controlled Logistics

Tue, Sep 04, 2018

When considering your temperature-controlled logistics needs, it is important to think about the compliance consideration steps in the drug development and delivery process being more than just getting biologic material from point A to point B. You need to keep in mind that your distribution needs are just one more integrated step in your business process flow. In addition, there are a large number of regulations and standards to consider regarding quality and document control, equipment validation, facilities, and personnel—just to name a few.

Cryoport’s Temperature Controlled Logistics Solutions Supporting Regenerative Medicine Advanced Therapy (RMAT) Clinical Development

Mon, Aug 27, 2018

Cryoport’s unique range of Cold Chain Logistics Solutions have been developed and implemented to support the most important and advanced drugs currently in the clinical development portfolios of many of the leading global biopharmaceutical companies and those that have been commercially approved – Novartis’ KYMRIAH™ and Gilead/Kite’s YESCARTA™. With the criticality of ensuring the highest quality, service and transparency to support the clinical and commercial aspects of each drug, Cryoport provides solutions that provide Chain of Custody, Condition, Identify and most important Chain of Compliance™ ensuring “zero defect” for the transportation and delivery of each lifesaving drug. Cryoport has worked closely with all our client partners to ensure maximum success in a complex environment. The dramatic increase of compounds being investigated in Regenerative Medicine over the last few years has required increased attention to supply chain requirements than ever before. Cryoport is proud to be partnered with the leading biopharmaceutical companies exploring the most advanced medical cures in the world.

Scientific Conclusions Are All About the Data--Choosing a Logistics Provider For Biomaterial Transport Should Be As Well

Mon, Aug 20, 2018

In our previous blog we discussed key considerations in the transport of critical biomaterials such as cell and gene therapies, in vitro fertilization shipments or large laboratory bio-sample moves. There we focused on challenges of customs processing, regional or country regulatory requirements and carrier choice and their associated processes. These are all part of critical risk assessment and mitigation strategies. Just as the development of the ground-breaking therapies are driven by good scientific methodologies, so should the choice temperature-controlled logistics providers be driven by unbiased data. Whether it be a standard integrator, or a specialty courier, being investigated for utilization data should drive the decision making process.

Considerations for Successful Biomaterial Transport into Challenging Countries

Thu, Aug 02, 2018

Successful research, development, manufacturing and commercialization in regenerative medicine is an epic challenge, with potentially a more epic reward of saving lives.

Almost equally challenging is working with partners domestically and around the globe to transport temperature controlled materials back and forth to keep progress moving forward.

It seems straightforward enough - Call your carrier of choice, provide addresses, contact names, documentation about the biomaterials and when you want it to arrive - simple, right?

Transporting Life: A Journey of Choice

Fri, Jul 27, 2018

Graduating classes of young professionals all over the world are preparing to meet new challenges set before them as the embark on a journey. The lessons and academic content taught in their respective fields of study still fresh in their minds as they interview for that perfect career. Some of them are hoping to solve age old problems and improve the human condition. The Biology and Life Sciences that they have learned in the classroom is now ready to be put to practical use for a worthy cause – discovery. In this new age of emerging personalized medicine, discovery of new characteristics of living cells is what this generation faces. New opportunities to do research that will be the future of treatments. So how will they transport the needed living cells for their research?

Dry Vapor: The Hero for the Ever-Growing CO2 Shortage

Tue, Jul 10, 2018

A carbon dioxide (CO2) shortage has been looming over the life sciences industry — yet many biopharma and biotech leaders alike have remained silent on this issue which is already shaking up our European counterparts. According to Gasworld, the European CO2 business is experiencing the worst supply situation it has seen in decades — primarily affecting Northern and Continental Europe.

Tags: Cold Chain, Clinical Trials Logistics, cryogenic frozen, alternative to dry ice shipping, temperature controlled logistics, cryogenic shipping, cold chain shipping

Cryoport is the Complete Logistics Solution for Your Clinical Programs

Thu, Oct 19, 2017

Cryoport is the leader in cryogenic and cold chain logistics solutions for the life sciences industry with their wide variety of Cryoport Express® dry vapor shippers, unparalleled informatics and global logistics expertise. The company has now expanded their profile with the launch of their ‘Cryoport. Certified. Cool.’ C3™ 2-8°C solution, which now gives the company complete capabilities to support the entire logistics continuum for regenerative medicine programs, specifically CAR-T therapies, and other temperature-controlled biologics or clinical materials.

Tags: Cold Chain, Clinical Trials Logistics

Cryoport Practices Quality by Design (QbD) Approaches When Developing New Products and Processes

Thu, Apr 13, 2017

Cryoport is the industry’s most trusted provider of cold chain logistics solutions for temperature-sensitive life sciences materials, serving biopharmaceutical, IVF and surrogacy and animal health organizations around the world. The company stands alone and is truly unrivaled due to their continuous improvement of their products and processes by executing advantageous Quality by Design (QbD) practices in support of their logistics solutions.

Cancer MoonShot 2020 Initiative Spurs Immunotherapy Research and Integrated Logistics Need

Thu, Jan 19, 2017

Providing $6.3 billion in funding for medical innovation to expedite the discovery, development and delivery of new treatments and cures, the 21st Century Cures Act (Cures) received overwhelming Congressional approval and was signed into law in December 2016.

Cryoport's Temperature Controlled Logistics Blog